Exposure related mutagens in urine of rubber workers associated with inhalable particulate and dermal exposure

Occupational and Environmental Medicine

Volumn 60, Issue 2, 2003, Pages 97-103

  Vermeulen, R ^a   Bos, R P ^b   Pertijs, J ^b   Kromhout, H ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYCLOHEXANE; DIMETHYL SULFOXIDE; MUTAGENIC AGENT; RUBBER; TOBACCO SMOKE;

ACETYLATION; ADULT; ARTICLE; GENOTOXICITY; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC ACTIVATION; MUTAGEN TESTING; MUTAGENICITY; OCCUPATIONAL EXPOSURE; PARTICULATE MATTER; PHENOTYPE; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; SKIN ABRASION; SKIN ABSORPTION; URINALYSIS; WORKER;

ACETYLATION; ADULT; AIR POLLUTANTS, OCCUPATIONAL; FEMALE; HUMANS; INHALATION EXPOSURE; MALE; MULTIVARIATE ANALYSIS; MUTAGENS; OCCUPATIONAL EXPOSURE; RUBBER; SKIN ABSORPTION; URINALYSIS;

NICOTIANA TABACUM; SALMONELLA TYPHIMURIUM; TYPHIMURIUM;

EID: 0037308308     PISSN: 13510711     EISSN: None     Source Type: Journal    
DOI: 10.1136/oem.60.2.97     Document Type: Article

References (43)

1. Baranski B, Indulski J, Janik SE, et al. Mutagenicity of airborne particulates in the rubber industry. J Appl Toxicol 1989;9:389-93.
2. Crebelli R, Falcone E, Aquilina G, et al. Mutagenicity studies in a tyre plant: in-vitro activity of urine concentrates and rubber chemicals. IARC Sci Publ 1984;289-95.
3. Falck K, Sorsa M, Vainio H, et al. Mutagenicity in urine of workers in rubber industry. Mutat Res 1980;79:45-52.
4. Bos RP, Kromhout H, Ikink H, et al. Mutagens in urine of non-smoking and smoking workers in an aircraft tyre retreading plant. Skin exposure as a causal factor? Mutat Res 1989;223:41-8.
5. Kromhout H, Swuste P, Boleij JS. Empirical modelling of chemical exposure in the rubber-manufacturing industry. Ann Occup Hyg 1994;38:3-22.
6. Vermeulen R, Heideman J, Bos RP, et al. Identification of dermal exposure pathways in the rubber manufacturing industry. Ann Occup Hyg 2000;44:551-60.
7. Vermeulen R, Bos RP, Kromhout H. Mutagenic exposure in the rubber manufacturing industry; an industry wide survey. Mutat Res 2001;490:27-34.
8. Benfeldt E, Serup J, Menne T. Effect of barrier perturbation on cutaneous salicylic acid penetration in human skin: in vivo pharmacokinetics using microdialysis and non-invasive quantification of barrier function. Br J Dermatol 1999;140:739-48.
9. Hart TB. Paraquat - a review of safety in agricuitural and horticultural use. Hum Toxicol 1987;6:13-18.
10. Yu XZ. [Biological monitoring of workers exposed to nitrofen and experimental study on its skin permeability]. Chung Hua Yu Fang I Hsueh Tsa Chih 1993;27:208-11.
11. Vermeulen R, Kromhout H, Bruynzeel DP, et al. Dermal exposure, hand washing and hand dermatitis in the rubber manufacturing industry. Epidemiology 2001;11:350-4.
12. Vermeulen R, de Hartog J, Swuste P, et al. Trends in exposure to inhalable particulate and dermal contamination in the rubber manufacturing industry: effectiveness of control measures implemented over a nine-year period. Ann Occup Hyg 2000;44:343-54.
13. Vermeulen R, Kromhout H, Bruynzeel DP, et al. Ascertainment of hand dermatitis using a symptom-based questionnaire; applicability in an industrial population. Contact Dermatitis 2000;42:202-6.
14. Vermeulen R, Wegh H, Bos RP, et al. Weekly patterns in smoking habits and influence on urinary cotinine and mutagenicity levels; confounding effect of non-smoking policies at the workplace. Cancer Epidemiol Biomarkers Prev 2000;9:1205-9.
15. Barlow RD, Thompson PA, Stone RB. Simultaneous determination of nicotine, cotinine and five additional nicotine metabolites in the urine of smokers using pre-column derivatisation and high-performance liquid chromatography. J Chromatogr 1987;419:375-80.
16. Parviainen MT, Barlow RD. Assessment of exposure to environmental tobacco smoke using a high-performance liquid chromatographic method for the simultaneous determination of nicotine and two of its metabolites in urine. J Chromatogr 1988;431:216-21.
17. Vermeulen R, Bos RP, de Hartog J, et al. Mutagenic profile of rubber dust and fume exposure in two rubber tire companies. Mutat Res 2000;468:165-71.
18. Kuile ter WM. Comparison of total dust measurements equipment at the workplace: Part II. Staub Reinhaltung der luft 1984;44:211-16.
19. Robbins MC. OSHA's wipe sampling policies and procedures. Sampling and analysis of toxic substances in the atmosphere - a symposium by ATSM. Boulder, CO: ATSM, 1979:79.
20. Kenny LC, Aitken R, Chalmers C, et al. A collaborative European study of personal inhalable aerosol sampler performance. Ann Occup Hyg 1997;41:135-53.
21. Durham WF, Wolff T. Measurement of the exposure of workers to pesticides. Bull WHO 1962;26:75-91.
22. NIOSH. Manual of analytical methods, 2nd edn. Cincinnati, OH: US Department of Health, Education and Welfare, 1977:77-157-A.
23. Hagiwara Y, Watanabe M, Oda Y, et al. Specificity and sensitivity of Salmonella typhimurium YG1041 and YG1042 strains possessing elevated levels of both nitroreductase and acetyltransferase activity. Mutat Res 1993;291:171-80.
24. Maron DM, Ames BN. Revised methods for the Salmonella mutagenicity test. Mutat Res 1983;113:173-215.
25. Krewski D, Leroux BG, Creason J, et al. Sources of variation in the mutagenic potency of complex chemical mixtures based on the Salmonella/microsome assay. Mutat Res 1992;276:33-59.
26. Grant DM, Tang BK, Kalow W. A simple test for acetylator phenotype using caffeine. Br J Clin Pharmacol 1984;17:459-64.
27. Bruynzeel DP, Boer de EM, Brouwer EJ, et al. Dermatitis in bulb growers. Contact Dermatitis 1993;29:11-15.
28. Mei van der IA, Boer de EM, Bruynzeel DP. Contact dermatitis in Alstroemeria workers. Occup Med Oxf 1998;48:397-404.
29. James W, Stein C. Estimation with quadratic loss. Proceedings of the fourth Berkeley symposium on mathematical statistics and probability. Berkeley, CA: University of California Press, 1961:361-80.
30. Efron B, Morris C. Limiting the risk of Bayes and empirical Bays estimators. Part II: the empirical Bayes case. J Am Stat Assoc 1972;67:130-9.
31. Seixas NS, Sheppard L. Maximizing accuracy and precision using individual and grouped exposure assessments. Scand J Work Environ Health 1996;22:94-101.
32. SAS Institute. SAS/STAT user's guide, version 6, 4th edn. Cary, NC: SAS Institute, Inc., 1990.
33. Thomas D, Stram D, Dwyer J. Exposure measurement error: influence on exposure-disease. Relationships and methods of correction. Annu Rev Public Health 1993;14:69-93.
34. Tielemans E, Kupper LL, Kromhout H, et al. Individual-based and group-based occupational exposure assessment: some equations to evaluate different strategies. Ann Occup Hyg 1998;42:115-19.
35. Alink GM, Sjogren M, Bos RP, et al. Effect of airborne particles from selected indoor and outdoor environments on gap-junctional intercellular communication. Toxicol Lett 1998;96-97:209-13.
36. Aungst BJ, Blake JA, Hussain MA. Contributions of drug solubilization, partitioning, barrier disruption, and salvent permeation to the enhancement of skin permeation of various compounds with fatty acids and amines. Pharm Res 1990;7:712-18.
37. Gunther C, Kecskes A, Staks T, et al. Percutaneous absorption of methylprednisolone aceponate following topical application of Advantan lotion on intact, inflamed and stripped skin of male volunteers. Skin Pharmacol Appl Skin Physiol 1998;11:35-42.
38. Higo N, Hinz RS, Lau DT, et al. Cutaneous metabolism of nitroglycerin in vitro. II. Effects of skin condition and penetration enhancement. Pharm Res 1992;9:303-6.
39. Boman A, Wahlberg JE. Percutaneous absorption of 3 organic solvents in the guinea pig (I). Effect of physical and chemical injuries to the skin. Contact Dermatitis 1989;21:36-45.
40. Sinues B, Perez J, Bernal ML, et al. Urinary mutagenicity and N-acetylation phenotype in textile industry workers exposed to arylamines. Cancer Res 1992;52:4885-9.
41. Bartsch H, Caporaso N, Coda M, et al. Carcinogen hemoglobin adducts, urinary mutagenicity, and metabolic phenotype in active and passive cigarette smokers. J Natl Cancer Inst 1990;82:1826-31.
42. Gabbani G, Hou SM, Nardini B, et al. GSTM1 and NAT2 genotypes and urinary mutagens in coke oven workers. Carcinogenesis 1996;17:1677-81.
43. Marcus PM, Vineis P, Rothman N. NAT2 slow acetylation and bladder cancer risk: a meta- analysis of 22 case-control studies conducted in the general population. Pharmacogenetics 2000;10:115-22.